company background image
STVN

Stevanato Group NYSE:STVN Stock Report

Last Price

US$26.91

Market Cap

US$7.1b

7D

-10.7%

1Y

55.1%

Updated

25 Sep, 2023

Data

Company Financials +

STVN Stock Overview

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for biopharma and healthcare.

STVN fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance3/6
Financial Health5/6
Dividends0/6

Stevanato Group S.p.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Stevanato Group
Historical stock prices
Current Share PriceUS$26.91
52 Week HighUS$36.30
52 Week LowUS$13.71
Beta0.81
1 Month Change-16.89%
3 Month Change-14.27%
1 Year Change55.10%
3 Year Changen/a
5 Year Changen/a
Change since IPO36.81%

Recent News & Updates

Stevanato: Secular Tailwinds In Biologics Support Downstream Demand

Sep 15

Stevanato Group: Undeniable Quality, But Lacking Upside

Jun 14

Recent updates

Stevanato: Secular Tailwinds In Biologics Support Downstream Demand

Sep 15

Stevanato Group: Undeniable Quality, But Lacking Upside

Jun 14

Stevanato Group S.p.A. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Mar 05
Stevanato Group S.p.A. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Stevanato Group and Transcoject to provide pre-fillable syringe polymer options for pharma

Jan 24

There's Reason For Concern Over Stevanato Group S.p.A.'s (NYSE:STVN) Price

Dec 28
There's Reason For Concern Over Stevanato Group S.p.A.'s (NYSE:STVN) Price

Stevanato Group Non-GAAP EPS of $0.14 beats by $0.01, revenue of $245.3M in-line

Nov 08

An Intrinsic Calculation For Stevanato Group S.p.A. (NYSE:STVN) Suggests It's 49% Undervalued

Aug 01
An Intrinsic Calculation For Stevanato Group S.p.A. (NYSE:STVN) Suggests It's 49% Undervalued

A Look At The Intrinsic Value Of Stevanato Group S.p.A. (NYSE:STVN)

Apr 19
A Look At The Intrinsic Value Of Stevanato Group S.p.A. (NYSE:STVN)

Shareholder Returns

STVNUS Life SciencesUS Market
7D-10.7%-2.0%-2.7%
1Y55.1%-1.0%16.8%

Return vs Industry: STVN exceeded the US Life Sciences industry which returned -2.9% over the past year.

Return vs Market: STVN exceeded the US Market which returned 15.1% over the past year.

Price Volatility

Is STVN's price volatile compared to industry and market?
STVN volatility
STVN Average Weekly Movement6.3%
Life Sciences Industry Average Movement7.3%
Market Average Movement5.5%
10% most volatile stocks in US Market14.2%
10% least volatile stocks in US Market2.5%

Stable Share Price: STVN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: STVN's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19495,260Franco Morohttps://www.stevanatogroup.com

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for biopharma and healthcare. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.

Stevanato Group S.p.A. Fundamentals Summary

How do Stevanato Group's earnings and revenue compare to its market cap?
STVN fundamental statistics
Market CapUS$7.12b
Earnings (TTM)US$155.79m
Revenue (TTM)US$1.09b

45.7x

P/E Ratio

6.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
STVN income statement (TTM)
Revenue€1.03b
Cost of Revenue€692.81m
Gross Profit€337.84m
Other Expenses€190.74m
Earnings€147.10m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.56
Gross Margin32.78%
Net Profit Margin14.27%
Debt/Equity Ratio16.2%

How did STVN perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

10%

Payout Ratio